DaVita (DVA) Competitors $142.56 0.00 (0.00%) Closing price 07/3/2025 03:30 PM EasternExtended Trading$141.45 -1.11 (-0.78%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DVA vs. ALGN, DXCM, HQY, MMSI, CAH, COR, EHC, HAE, ITGR, and MCKShould you be buying DaVita stock or one of its competitors? The main competitors of DaVita include Align Technology (ALGN), DexCom (DXCM), HealthEquity (HQY), Merit Medical Systems (MMSI), Cardinal Health (CAH), Cencora (COR), Encompass Health (EHC), Haemonetics (HAE), Integer (ITGR), and McKesson (MCK). These companies are all part of the "medical" sector. DaVita vs. Its Competitors Align Technology DexCom HealthEquity Merit Medical Systems Cardinal Health Cencora Encompass Health Haemonetics Integer McKesson Align Technology (NASDAQ:ALGN) and DaVita (NYSE:DVA) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, media sentiment, dividends, valuation, analyst recommendations, risk and earnings. Do insiders and institutionals believe in ALGN or DVA? 88.4% of Align Technology shares are owned by institutional investors. Comparatively, 90.1% of DaVita shares are owned by institutional investors. 0.7% of Align Technology shares are owned by insiders. Comparatively, 2.0% of DaVita shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media prefer ALGN or DVA? In the previous week, Align Technology had 13 more articles in the media than DaVita. MarketBeat recorded 23 mentions for Align Technology and 10 mentions for DaVita. DaVita's average media sentiment score of 1.35 beat Align Technology's score of 1.22 indicating that DaVita is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 16 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DaVita 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher valuation and earnings, ALGN or DVA? DaVita has higher revenue and earnings than Align Technology. DaVita is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlign Technology$4.00B3.57$421.36M$5.4935.87DaVita$12.82B0.84$936.34M$10.0914.13 Which has more risk and volatility, ALGN or DVA? Align Technology has a beta of 1.63, indicating that its share price is 63% more volatile than the S&P 500. Comparatively, DaVita has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500. Is ALGN or DVA more profitable? Align Technology has a net margin of 10.29% compared to DaVita's net margin of 6.63%. DaVita's return on equity of 176.11% beat Align Technology's return on equity.Company Net Margins Return on Equity Return on Assets Align Technology10.29% 13.52% 8.36% DaVita 6.63%176.11%4.66% Do analysts prefer ALGN or DVA? Align Technology presently has a consensus price target of $241.25, indicating a potential upside of 22.51%. DaVita has a consensus price target of $164.50, indicating a potential upside of 15.39%. Given Align Technology's stronger consensus rating and higher probable upside, research analysts clearly believe Align Technology is more favorable than DaVita.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Align Technology 1 Sell rating(s) 4 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.67DaVita 1 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryAlign Technology beats DaVita on 10 of the 17 factors compared between the two stocks. Get DaVita News Delivered to You Automatically Sign up to receive the latest news and ratings for DVA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DVA vs. The Competition Export to ExcelMetricDaVitaMED IndustryMedical SectorNYSE ExchangeMarket Cap$10.76B$3.91B$5.53B$20.73BDividend YieldN/A1.27%5.24%3.72%P/E Ratio14.1335.6227.5028.09Price / Sales0.8418.00421.0238.31Price / Cash7.4524.0336.8922.53Price / Book29.524.398.044.58Net Income$936.34M$189.47M$3.18B$986.06M7 Day Performance0.60%-1.09%2.82%2.79%1 Month Performance4.19%-3.76%3.70%5.42%1 Year Performance3.34%8.45%35.41%14.63% DaVita Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DVADaVita4.2967 of 5 stars$142.56flat$164.50+15.4%+3.3%$10.76B$12.82B14.1376,000Positive NewsALGNAlign Technology4.5455 of 5 stars$189.33+0.4%$241.25+27.4%-19.1%$13.72B$4.00B34.4920,945Positive NewsDXCMDexCom4.8929 of 5 stars$87.29+1.1%$98.50+12.8%-25.4%$34.23B$4.03B65.147,600Positive NewsHQYHealthEquity3.7258 of 5 stars$104.76-0.1%$118.09+12.7%+19.1%$9.06B$1.20B76.473,120MMSIMerit Medical Systems4.3337 of 5 stars$93.480.0%$109.11+16.7%+9.0%$5.52B$1.36B45.827,400News CoverageCAHCardinal Health4.8206 of 5 stars$167.92+0.4%$157.43-6.2%+72.2%$40.08B$226.83B26.2046,500Positive NewsEx-DividendAnalyst RevisionCORCencora4.6719 of 5 stars$299.48+0.0%$306.33+2.3%+33.1%$58.05B$293.96B34.7442,000Positive NewsAnalyst RevisionEHCEncompass Health4.8439 of 5 stars$122.60+0.3%$127.00+3.6%+38.3%$12.36B$5.37B25.3340,000Positive NewsEx-DividendHAEHaemonetics4.8734 of 5 stars$74.77+1.3%$96.80+29.5%-8.7%$3.59B$1.36B22.593,023ITGRInteger3.6152 of 5 stars$122.92+0.3%$145.00+18.0%+5.2%$4.29B$1.75B58.2611,000MCKMcKesson4.3488 of 5 stars$732.50+0.9%$696.42-4.9%+23.2%$91.64B$359.05B28.3675,000Trending NewsAnalyst Revision Related Companies and Tools Related Companies ALGN Competitors DXCM Competitors HQY Competitors MMSI Competitors CAH Competitors COR Competitors EHC Competitors HAE Competitors ITGR Competitors MCK Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:DVA) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DaVita Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DaVita With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DVA Stock Alerts